Tag: retinal disease

Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa

First modules of BLA submitted to FDA under rolling review, with full submission anticipated in early 2026MCO-010 BLA for retinitis pigmentosa is eligible for priority review...

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential approval

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsRetinal disease

After 80+ Years, the National Hardware Show Transforms Itself with a Bold New Mission: Getting Products to Market Faster, Smarter, and More Profitably

[Latest] Global Monocalcium Phosphate Market Size/Share Worth USD 5.94 Billion by 2034 at a 5.94 CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

1-Hour Payday Loans with No Credit Check And Guaranteed Approval – Brand New Feature in Wizzay’s Loan Program in 2025

Tag: retinal disease

Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us